אפרקס 30000 ישראל - עברית - Ministry of Health

אפרקס 30000

j-c health care ltd - erythropoietin human recombinant - תמיסה להזרקה - erythropoietin human recombinant 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) orb: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicate

ריספרדל קונסטה 25 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 25 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 25 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 25 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 25 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 25 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 37.5 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 37.5 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 37.5 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 37.5 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 37.5 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 37.5 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 50 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 50 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 50 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 50 מג ישראל - עברית - Ministry of Health

ריספרדל קונסטה 50 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 50 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

סטלרה 45 מג ויאל ישראל - עברית - Ministry of Health

סטלרה 45 מג ויאל

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara™ is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to,or have contraindication to or who are intolerant to other systemic therapies including ciclosporin,methotrexate and psoralen plus u.v (puva).

סטלרה מזרק מוכן לשימוש ישראל - עברית - Ministry of Health

סטלרה מזרק מוכן לשימוש

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to, or have contraindication to or who are intolerant to other systemic therapies including ciclosporin, methotrexate and psoralen plus u.v (puva).

סימפוני ישראל - עברית - Ministry of Health

סימפוני

j-c health care ltd - golimumab - תמיסה להזרקה - golimumab 50 mg / 0.5 ml - golimumab - golimumab - rheumatoid arthritis :simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (dmard) therapy including mtx has been inadequate.psoriatic arthritis :simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (dmard) therapy has been inadequate.ankylosing spondylitis :simponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.